The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis
Open accessAbstract
SUMMARY Wnt signaling plays a critical role in embryonic development, and genetic aberrations in this network have been broadly implicated in colorectal cancer. We find that the Wnt receptor Frizzled2 (Fzd2) and its ligands Wnt5a/b are elevated in metastatic liver, lung, colon, and breast cancer cell lines and in high-grade tumors, and that their expression correlates with markers of epithelial-mesenchymal transition (EMT). Pharmacologic and genetic perturbations reveal that Fzd2 drives EMT and cell migration through a previously unrecognized, non-canonical pathway that includes Fyn and Stat3. A gene signature regulated by this pathway predicts metastasis and overall survival in patients. We have developed an antibody to Fzd2 that reduces cell migration and invasion and inhibits tumor growth and metastasis in xenografts. We propose that targeting this pathway could provide benefit for patients with tumors expressing high levels of Fzd2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
The WEKA data mining software: an update
Hall, M., Frank, E., Holmes, G., Pfahringer, B., Reutemann, P., & Witten, I. H. (2009) · ACM SIGKDD Explorations Newsletter · doi:10.1145/1656274.1656278 · Cited by 17,750
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
Breast cancer metastasis: markers and models
Weigelt, B., Peterse, J. L., & van't Veer, L. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1670 · Cited by 2,232
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
Lee, J. M., Dedhar, S., Kalluri, R., & Thompson, E. W. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601018 · Cited by 2,019
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis
Harrison, C., Kiladjian, J.-J., Al-Ali, H. K., Gisslinger, H., Waltzman, R., Stalbovskaya, V., McQuitty, M., Hunter, D. S., Levy, R., Knoops, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110556 · Cited by 1,825
Wnt signalling and its impact on development and cancer
Klaus, A., & Birchmeier, W. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2389 · Cited by 1,595
Caught up in a Wnt storm: Wnt signaling in cancer
Giles, R. H., van Es, J. H., & Clevers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00005-2 · Cited by 1,482
Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
Wilson, T. R., Fridlyand, J., Yan, Y., Penuel, E., Burton, L., Chan, E., Peng, J., Lin, E., Wang, Y., Sosman, J., et al. (2012) · Nature · doi:10.1038/nature11249 · Cited by 1,134 · cited 2×
“RTK-mediated signaling pathways share multiple downstream signaling elements, and inhibiting the dominant RTK often results in the compensatory recruitment of downstream components by other RTKs, an important mechanism of chemoresistance (Wilson et al., 2012).”
O'Shea, J. J., Gadina, M., & Schreiber, R. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00701-8 · Cited by 1,119
Stattic: a small-molecule inhibitor of STAT3 activation and dimerization
Schust, J., Sperl, B., Hollis, A., Mayer, T. U., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.018 · Cited by 1,105
Cancer stem cells: mirage or reality?
Gupta, P. B., Chaffer, C. L., & Weinberg, R. A. (2009) · Nature Medicine · doi:10.1038/nm0909-1010 · Cited by 979
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Anastassiadis, T., Deacon, S. W., Devarajan, K., Ma, H., & Peterson, J. R. (2011) · Nature Biotechnology · doi:10.1038/nbt.2017 · Cited by 919
Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast
Scheel, C., Eaton, E. N., Li, S. H.-J., Chaffer, C. L., Reinhardt, F., Kah, K.-J., Bell, G., Guo, W., Rubin, J., Richardson, A. L., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.029 · Cited by 858
Ye, Q.-H., Qin, L.-X., Forgues, M., He, P., Kim, J. W., Peng, A. C., Simon, R., Li, Y., Robles, A. I., Chen, Y., et al. (2003) · Nature Medicine · doi:10.1038/nm843 · Cited by 850
Davis, S., Vanhoutte, P., Pagès, C., Caboche, J., & Laroche, S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04563.2000 · Cited by 622
Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors
Grumolato, L., Liu, G., Mong, P., Mudbhary, R., Biswas, R., Arroyave, R., Vijayakumar, S., Economides, A. N., & Aaronson, S. A. (2010) · Genes & Development · doi:10.1101/gad.1957710 · Cited by 470
The epithelial–mesenchymal transition (EMT) phenomenon
Savagner, P. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq292 · Cited by 413
Duncia, J. V., Santella, J. B., Higley, C. A., Pitts, W. J., Wityak, J., Frietze, W. E., Rankin, F. W., Sun, J.-H., Earl, R. A., Tabaka, A. C., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00522-8 · Cited by 401
Dissanayake, S. K., Wade, M., Johnson, C. E., O'Connell, M. P., Leotlela, P. D., French, A. D., Shah, K. V., Hewitt, K. J., Rosenthal, D. T., Indig, F. E., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700075200 · Cited by 374
Wen, Z. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.11.2062 · Cited by 325
Fuchs, B. C., Fujii, T., Dorfman, J. D., Goodwin, J. M., Zhu, A. X., Lanuti, M., & Tanabe, K. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2460 · Cited by 309
EGF-R signaling through Fyn kinase disrupts the function of integrin α6β4 at hemidesmosomes
Mariotti, A., Kedeshian, P. A., Dans, M., Curatola, A. M., Gagnoux-Palacios, L., & Giancotti, F. G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105017 · Cited by 305
Gupta, S., Iljin, K., Sara, H., Mpindi, J. P., Mirtti, T., Vainio, P., Rantala, J., Alanen, K., Nees, M., & Kallioniemi, O. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0244 · Cited by 278
Not so strange bedfellows: G-protein-coupled receptors and Src family kinases
Luttrell, D. K., & Luttrell, L. M. (2004) · Oncogene · doi:10.1038/sj.onc.1208162 · Cited by 221
Guo, L., Chen, C., Shi, M., Wang, F., Chen, X., Diao, D., Hu, M., Yu, M., Qian, L., & Guo, N. (2013) · Oncogene · doi:10.1038/onc.2012.573 · Cited by 209
Cancer metastasis as a therapeutic target
Sleeman, J., & Steeg, P. S. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.039 · Cited by 198
Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity
Wu, Z.-Q., Brabletz, T., Fearon, E., Willis, A. L., Hu, C. Y., Li, X.-Y., & Weiss, S. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203015109 · Cited by 160
Suramin analogues as subtype-selective G protein inhibitors.
Freissmuth, M., Boehm, S., Beindl, W., Nickel, P., IJzerman, A. P., HOHENEGGER, M., & Nanoff, C. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08769-3 · Cited by 143
Balanis, N. G., Wendt, M. K., Schiemann, B. J., Wang, Z., Schiemann, W. P., & Carlin, C. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.475277 · Cited by 141
Deka, J., Wiedemann, N., Anderle, P., Murphy-Seiler, F., Bultinck, J., Eyckerman, S., Stehle, J., André, S., Vilain, N., Zilian, O., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0148 · Cited by 132
EGR1 and the ERK‐ERF axis drive mammary cell migration in response to EGF
Tarcic, G., Avraham, R., Pines, G., Amit, I., Shay, T., Lu, Y., Zwang, Y., Katz, M., Ben‐Chetrit, N., Jacob‐Hirsch, J., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-194654 · Cited by 116
Payne, G., Shoelson, S. E., Gish, G. D., Pawson, T. J., & Walsh, C. T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4902 · Cited by 116
Smith, C. A., Dho, S. E., Donaldson, J. G., Tepaß, U., & McGlade, C. J. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-01-0026 · Cited by 105
Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2
Li, C., Chen, H., Hu, L., Xing, Y., Sasaki, T., Villosis, M. F., Li, J., Nishita, M., Minami, Y., & Minoo, P. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-11 · Cited by 103
Exploiting polypharmacology for drug target deconvolution
Gujral, T. S., Peshkin, L., & Kirschner, M. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403080111 · Cited by 102
Self-citationStat3 promotes directional cell migration by regulating Rac1 activity via its activator βPIX
Teng, T., Lin, B., Manser, E., Ng, D. C. H., & Cao, X. (2009) · Journal of Cell Science · doi:10.1242/jcs.057109 · Cited by 99
Wnt5b–Ryk pathway provides directional signals to regulate gastrulation movement
Lin, S., Baye, L. M., Westfall, T. A., & Slusarski, D. C. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200912128 · Cited by 95
The Inhibitory G Protein Gi Identified as Pertussis Toxin-Catalyzed ADP-Ribosylation
Katada, T. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b212024 · Cited by 72
Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays
Gujral, T. S., Karp, R. L., Finski, A., Chan, M. M., Schwartz, P. E., MacBeath, G., & Sorger, P. K. (2012) · Oncogene · doi:10.1038/onc.2012.378 · Cited by 72
Self-citationJordan, N. V., Prat, A., Abell, A. N., Zawistowski, J. S., Sciaky, N., Karginova, O. A., Zhou, B., Golitz, B. T., Perou, C. M., & Johnson, G. L. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01443-12 · Cited by 69
Quantifying information transfer by protein domains: Analysis of the Fyn SH2 domain structure
Lenaerts, T., Ferkinghoff‐Borg, J., Stricher, F., Serrano, L. G., Schymkowitz, J. W. H., & Rousseau, F. (2008) · BMC Structural Biology · doi:10.1186/1472-6807-8-43 · Cited by 40
Tofacitinib in Active Ulcerative Colitis
Cottone, M., Orlando, A., & Papi, C. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1211073 · Cited by 5
Cited by
Zhan, T., Rindtorff, N., & Boutros, M. (2017) · Oncogene · doi:10.1038/onc.2016.304 · Cited by 2,626
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance
Miyamoto, D. T., Zheng, Y., Wittner, B. S., Lee, R. J., Zhu, H., Broderick, K. T., Desai, R., Fox, D. B., Brannigan, B. W., Trautwein, J., et al. (2015) · Science · doi:10.1126/science.aab0917 · Cited by 705
The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling
Shorning, B. Y., Dass, M. S., Smalley, M. J., & Pearson, H. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124507 · Cited by 616
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells
Kröger, C., Afeyan, A., Mraz, J., Eaton, E. N., Reinhardt, F., Khodor, Y. L., Thiru, P., Bierie, B., Ye, X., Burge, C. B., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812876116 · Cited by 499
Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis
Vu, T., & Datta, P. (2017) · Cancers · doi:10.3390/cancers9120171 · Cited by 496
Metadata
- Authors
- Gujral, T. S., Chan, M., Peshkin, L., Sorger, P. K., Kirschner, M. W., & MacBeath, G.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 159
- Issue
- 4
- Pages
- 844-856
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W1971402898
- Cited by
- 350
- References
- 46
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.